Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 11.0696 | 99 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 11.5963 | 99 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 11.769 | 99 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 10.9457 | 99 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 11.3002 | 99 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 11.1564 | 99 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 11.1465 | 99 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 11.1802 | 99 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 10.8924 | 99 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 10.8071 | 99 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 10.8495 | 99 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 11.0112 | 99 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 11.2404 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 10.9619 | 99 |